Physician profile
Daniel Bahat
NPI 1982286670
$1,114.25
in general payments reported to CMS, 2019-2025
8 companies · $531 in 2025
The $531 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $346 · 2024: $236 · 2025: $531.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,114.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,114.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $241.10 | 2024-2025 | |
| Urgo Medical North America, LLC | $201.06 | 2023-2024 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Polynovo North America LLC | $150.84 | 2025 | Novosorb Btm |
| Dilon Technologies, INC. | $145.55 | 2023-2024 | Hemoblast Bellows |
| Avita Medical Americas, LLC | $144.21 | 2025 | Recell |
| Convatec INC. | $123.74 | 2023 | |
| Motiva USA, LLC | $88.59 | 2025 | |
| Innovation Technologies INC | $19.16 | 2024 | Irrisept |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Bahat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.